Billy Amzal

Prior to joining Phastar, Billy led the model-based drug development team at Novartis. Then, he developed and led implementation of statistical methodologies for high impact research sponsored by public and global Health Agencies (EFSA, Global Fund, US NIH). Billy has then been Senior VP at Certara in charge of data and decision analytics and CEO/Chief statistician at Quinten Health an AI company pioneering digital twins and disease modeling.

Billy still acts as statistical expert for public health orgs (EMA, WHO, Gates Foundation).

He led hundreds of trial design and analytics projects, authored more than 100 publications, defended/submitted 100 regulatory and reimbursements dossiers, and led hundreds of data modelling or machine learning projects.